Navigation Links
Acquisitions, Project Announcements & Trend Analysis News for Oxygen Biotherapeutics, Glu Mobile, Cisco Systems, Barrick Gold, CVS Caremark
Date:11/6/2013

NEW YORK, November 6, 2013 /PRNewswire/ --

Market Buzz Report, a penny stock newsletter provided, issues latest updates and news on Oxygen Biotherapeutics, Inc.(NASDAQ: OXBT), Glu Mobile Inc.(NASDAQ: GLUU), Cisco Systems, Inc.(NASDAQ: CSCO), Barrick Gold Corporation (USA)(NYSE: ABX), CVS Caremark Corporation(NYSE: CVS).

Oxygen Biotherapeutics, Inc.(NASDAQ: OXBT) was the most active stock gainer in Tuesday with a  gain of 62.72% to $8.38 on hefty volume of 39.61 million shares - 18X its average volume of 2.35 million shares.

Free Urgent Insider Catalyst Report For OXBT Available Here:  http://marketbuzzreport.com/index.php?code=OXBT  (Or Copy and paste the URL into your browser)

Last week, Phyxius Pharma, Inc. and Oxygen Biotherapeutics, Inc., (OXBT), today announced that researchers at the Duke Clinical Research Institute (DCRI), part of the Duke University School of Medicine, recently published findings of a meta-analysis of multiple clinical trials that evaluated the use of levosimendan in patients undergoing heart surgery.

Glu Mobile Inc.(NASDAQ: GLUU) is having operations in China since the last six years after acquisition of MIG. Even though the deal resulted in a number of financial issues, the region is now clearly important to the future of the firm.

Is GLUU a Solid Buy After The Recent Rally? Get Free Special Trend Analysis Here  http://marketbuzzreport.com/index.php?code=GLUU  (Or Copy and paste the URL into your browser)

Glu has seen the Chinese and APAC regions as growth regions even as revenues from North America have declined.  The company derives one third of its revenues from this region, more than Europe.
Glu's CEO Niccolo de Masi opined that China is already the firm's second largest market after the US.

Cisco Systems, Inc.(NASDAQ: CSCO) is rallying ahead of tomorrow's anticipated Insieme event. Insieme, an 85%-owned Cisco unit filled with star engineers, is expected to show off a networking platform featuring switches that can dynamically adapt to an application's needs, and which will deliver network and security services to said apps. It's also expected to reveal high-performance, ASIC-based, switches supporting its platform, and developer APIs for interacting with them.

Free Urgent Insider Catalyst Report For CSCO: Available Here: http://marketbuzzreport.com/index.php?code=CSCO  (Or Copy and paste the URL into your browser)

Though Cisco has shied away from referring to Insieme's solution as a software-defined networking (SDN) platform, it's viewed as part of Cisco's response to the rise of SDN solutions featuring software-based controllers that can interact with commodity hardware, and which are seen as a huge threat to Cisco's high-margin switch/router sales.

Bankers still have work to do to sell all of Barrick Gold Corporation (USA)(NYSE: ABX) $3B equity offering, but insiders say there is no talk of re-pricing the deal.The banks reportedly sold a large chunk of the 163.5M-share offering last Thursday night and Friday morning, but the gold price fell on Friday and ABX shares dropped well below the $18.35 offer price; a large short position also is working against the stock.But insiders say they are optimistic the deal will sell this week; large funds are taking time to do their homework, and index funds that have to own ABX have not bought in yet, they say.

Free Urgent Insider Catalyst Report For ABX Available Here: http://marketbuzzreport.com/index.php?code=ABX  (Or Copy and paste the URL into your browser)

CVS Caremark Corporation(NYSE: CVS) reports a nice jump in profits during Q3 as its pharmacy business thrived and a legal settlement factored in.Revenue in the Pharmacy Services segment rose 7.8% to $19.5B on higher claims and drug prices, while the Retail Pharmacy segment saw a 5% jump in sales to $16.3B on higher prescription volume.The company raised and narrowed its guidance for full year EPS.

How Should Investors Trade CVS After The Recent Volatility? Find Out Here http://marketbuzzreport.com/index.php?code=CVS  (Or Copy and paste the URL into your browser)

USMarketBuzz.com is an investment community that Focuses on MicroCap Securities. USMarketBuzz.com is an  authorative authentic Google News Site and  Leading Provider of Investment Awareness and Featured Company Profiles. If you would like more information regarding our news coverage solutions, please visit http://www.USMarketBuzz.com/   for more details. Get an edge on the market with our Premium News Alerts   that are FREE for a limited time at http://www.USMarketBuzz.com/. Follow us on Facebook: https://www.facebook.com/usmarket.buzz Sign up for our FREE SMS News alerts delivered directly to your mobile phone by texting the word PREPROMO to 27126.  (SMS alerts are free, however data rates may apply, check your wireless plan for details.)

DISCLAIMER:  FNNewswire (FNNW) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNNW is NOT affiliated in any manner with MarketBuzz Reports, USMarketBuzz.com or any company mentioned herein.  The commentary, views and opinions expressed in this release by MarketBuzz Reports and USMarketBuzz.com are solely those of the MarketBuzz Reports & USMarketBuzz.com and are not shared by and do not reflect in any manner the views or opinions of FNNW. The companies that are discussed herein may or may not have approved the statements made in this release.  FNNW is not liable for any investment decisions by its readers or subscribers FNNW and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNNW was not compensated by any public company mentioned herein to disseminate this press release.

FNNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.  

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNNW undertakes no obligation to update such statements.

FNNW Contact Information:
Company:  FN Newswire
Contact email: editor@fnnewswire.com
U.S. Phone: +1(954)345-0611

 


'/>"/>
SOURCE FN Media Group, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. New Drug Applications, FDA Approvals, Approved Acquisitions, Divestitures and Licensing Agreements - Research Report on Merck, Allergan, Mylan, AstraZeneca, and GlaxoSmithKline
2. Acquisitions, Clinical Trial Results, Date Extensions and Financial Results - Research Report on Endo, Astex, Auxilium, Accuray, and BioScrip
3. Rancho BioSciences Will Present the Accelerated Cure Project Multiple Sclerosis Data Curation White Paper at the tranSMART Fall Developers Meeting, Paris, November 5-7
4. NPL leads research project to help deliver 10x faster computer processing speeds
5. Verve Offers World’s 1st Non-GMO Project Verified Gum
6. "Project Recovery" verarbeitet ungenutzte Blutprodukte aus kanadischen Blutspenden zu Hämophiliemedikamenten für Entwicklungsländer
7. ChanTest Initiates Project for the US FDA to Improve Understanding of the Interaction of Tobacco Products with Human Nicotinic Receptors
8. Bayer Supports 150 Volunteer Projects Across the Globe During 150th Anniversary Year
9. EFIC-Grünenthal-Grant Awards Seven Innovative Research Projects
10. Project Oncology CME Series Launches on ReachMD, Offering Learners a Wide Array of Certified Oncology Activities Across an Integrated Platform
11. How to Kill Mold While Saving Thousands of Dollars on Mold Remediation Projects Explained by My Cleaning Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... Whitehouse, NJ (PRWEB) , ... January 18, 2017 ... ... access to more and more E&L expertise. Within Albany Molecular Research, Inc. (AMRI), ... doubled in the past year and is planned for further growth in 2017. ...
(Date:1/18/2017)... ... 2017 , ... Researchers from a new study are stating that if levels of ... cancer treatment, this indicates there is still remaining prostate cancer cells that are more likely ... test has always been an indicator of whether a man’s prostate cancer is growing ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... the publishing of the latest paper by its Science Editor, Dr. Elisabeth Bik, ... Tijdschrift voor Medische Microbiologie). Dr. Bik joined uBiome in October 2016 from her ...
(Date:1/18/2017)...  HUYA Bioscience International, (HUYA), the leader in accelerating ... pharmaceutical innovations, announced today a strategic collaboration agreement with ... (referred to as CAS Innovation). The collaboration will focus ... scientists at CAS to meet the medical needs of ... first company to have recognized China,s ...
Breaking Biology Technology:
(Date:12/15/2016)... , Dec 15, 2016 ... Research and Markets has announced the addition ... offering. The report forecasts the global military biometrics market ... The report has been prepared based on an in-depth market ... and its growth prospects over the coming years. The report also includes ...
(Date:12/15/2016)... , Dec. 14, 2016 "Increase in ... biometrics market" The mobile biometrics market is expected to ... 49.33 billion by 2022, at a CAGR of 29.3% ... factors such as the growing demand for smart devices, ... transactions. "Software component is expected to grow ...
(Date:12/8/2016)... 2016  Singulex, Inc., the leader in Next Generation ... a license and supply agreement with Thermo Fisher Scientific, ... Singulex access to Thermo Scientific BRAHMS PCT (Procalcitonin), a ... used to diagnose systemic bacterial infection and sepsis and ... aid in assessing the risk of critically ill patients ...
Breaking Biology News(10 mins):